Patients with T2D have a reduced number of islet epsilon cells, and fasted plasma levels of ghrelin are reduced, although it is not possible to discern how much of this circulatory ghrelin reduction is derived from islet production [197]. The gene discussed is GHRL; the disease is type 2 diabetes mellitus.